Literature DB >> 2394624

Minimization of small bowel volume within treatment fields utilizing customized "belly boards".

T G Shanahan1, M P Mehta, K L Bertelrud, D A Buchler, L E Frank, M A Gehring, S S Kubsad, P C Utrie, T J Kinsella.   

Abstract

Thirty consecutive patients with pelvic malignancies were evaluated prospectively for the impact of a novel bowel minimization device ("belly board") on the volume of small bowel included within a four field pelvic radiation plan. A customized polyurethane and styrofoam bowel immobilization mold was created for each patient in the prone position. Using contrast enhanced CT scanning on a dedicated radiation treatment planning scanner, we imaged the location of the small intestine in the supine position and the prone position aided by the "belly board". Custom in-house interactive image analysis software was developed to allow volumetric determination of small bowel within the treatment portals. The mean small bowel volume was reduced by 66% (299 cm3 to 102 cm3), comparing the standard supine position to the prone position assisted by the "belly board". In 13 patients without prior pelvic surgery, the small bowel volume reduction was a more dramatic 74% (334 cm3 to 88 cm3). All patients were found to benefit from this prone "belly board" setup regardless of body habitus, weight, and age. Compliance with the set-up including use of bladder distension was excellent. All patients completed their pelvic radiotherapy without requiring a treatment break. Weight loss at completion averaged less than 5%. Seventy-six percent of patients experienced little or no diarrhea. This technique is comfortable, inexpensive, highly reproducible, and permits maximal bowel displacement from standard pelvic radiotherapy fields.

Entities:  

Mesh:

Year:  1990        PMID: 2394624     DOI: 10.1016/0360-3016(90)90559-3

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  11 in total

1.  Prognostic significance of adverse events associated with preoperative radiotherapy for rectal cancer.

Authors:  Soichiro Ishihara; Toshiaki Watanabe; Takuya Akahane; Ryu Shimada; Atsushi Horiuchi; Hajima Shibuya; Tamuro Hayama; Hideki Yamada; Keijiro Nozawa; Hiroshi Igaki; Keiji Matsuda
Journal:  Int J Colorectal Dis       Date:  2011-02-22       Impact factor: 2.571

Review 2.  Radiation enteritis.

Authors:  Ali H Harb; Carla Abou Fadel; Ala I Sharara
Journal:  Curr Gastroenterol Rep       Date:  2014

3.  Use of a tissue expander and a polyglactic acid (Vicryl) mesh to reduce radiation enteritis: case report and literature review.

Authors:  A Abhyankar; M Jenney; S N Huddart; D W O Tilsley; R Cox; M Saad
Journal:  Pediatr Surg Int       Date:  2005-10-20       Impact factor: 1.827

4.  Phase I trial of pelvic nodal dose escalation with hypofractionated IMRT for high-risk prostate cancer.

Authors:  Jarrod B Adkison; Derek R McHaffie; Søren M Bentzen; Rakesh R Patel; Deepak Khuntia; Daniel G Petereit; Theodore S Hong; Wolfgang Tomé; Mark A Ritter
Journal:  Int J Radiat Oncol Biol Phys       Date:  2010-12-14       Impact factor: 7.038

Review 5.  Late small bowel toxicity after adjuvant treatment for rectal cancer.

Authors:  Matthias Guckenberger; Michael Flentje
Journal:  Int J Colorectal Dis       Date:  2005-07-29       Impact factor: 2.571

Review 6.  Gastrointestinal radiation injury: prevention and treatment.

Authors:  Abobakr K Shadad; Frank J Sullivan; Joseph D Martin; Laurence J Egan
Journal:  World J Gastroenterol       Date:  2013-01-14       Impact factor: 5.742

7.  Sodium butyrate enemas in the treatment of acute radiation-induced proctitis in patients with prostate cancer and the impact on late proctitis. A prospective evaluation.

Authors:  Andrea Hille; Markus K A Herrmann; Tereza Kertesz; Hans Christiansen; Robert M Hermann; Olivier Pradier; Heinz Schmidberger; Clemens-F Hess
Journal:  Strahlenther Onkol       Date:  2008-12-24       Impact factor: 3.621

8.  Recent advances in the management of radiation colitis.

Authors:  Jannis Kountouras; Christos Zavos
Journal:  World J Gastroenterol       Date:  2008-12-28       Impact factor: 5.742

Review 9.  [Indications for neoadjuvant therapy in rectal carcinoma].

Authors:  F Zimmermann; M Molls
Journal:  Chirurg       Date:  2003-10       Impact factor: 0.955

10.  Acute small-bowel toxicity during neoadjuvant combined radiochemotherapy in locally advanced rectal cancer: determination of optimal dose-volume cut-off value predicting grade 2-3 diarrhoea.

Authors:  Tina Reis; Edwin Khazzaka; Grit Welzel; Frederik Wenz; Ralf-Dieter Hofheinz; Sabine Mai
Journal:  Radiat Oncol       Date:  2015-01-31       Impact factor: 3.481

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.